• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Ascensia Diabetes Care highlights women helping to advance diabetes care

November 30, 2017 By Sarah Faulkner

World Diabetes Day - Ascensia Diabetes CareIn support of World Diabetes Day earlier this month, Ascensia Diabetes Care published 30 portraits of women who are working to advance diabetes care.

The company’s CEO, Michael Kloss, said he was inspired by the theme of this year’s annual event, Women and Diabetes, and turned within the company for nominations of inspiring women.

“We initially looked for about 10 – 12 images of women and we were very happy that we got 30 nominations, so we decided to take all of them. It’s really a broad spectrum of inspiring women who have made a major impact on the field of diabetes, including internal contributors who really made a difference to our teams,” he told Drug Delivery Business News.

Among the women featured in this collection are Rosa Almeida, a Type I diabetic who has worked in the diabetes arena for 13 years, and Elsa Soto, who was diagnosed with gestational diabetes four years ago. Both Soto and Almedia are Ascensia employees.

All of the portraits were individually painted by artists using tablets, Kloss said. Women from within Ascensia are featured in the collection, as well as advocates and healthcare workers from around the world.

Notably, the portrait of Helen Free is featured prominently on the company’s display page. Free invented the technology used to make the first indicator to detect glucose in 1956.

“The accomplishments of this diverse and impactful group of women are incredible and between them they have made enormous contributions to the field of diabetes. However, we shouldn’t forget the many women who are not part of this campaign. The women who have been profiled here, represent the millions of patients, doctors, nurses, researchers, caregivers and advocates who work tirelessly each and every day to advance the treatment and management of diabetes,” Kloss said in a prepared statement.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Ascensia Diabetes Care

IN CASE YOU MISSED IT

  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Go-Pen ApS wins FDA nod for user-filled insulin pen

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS